Magnetar Financial LLC
Q4 2019 13F-HR Holdings
Net value change ($000)
—
New positions
476
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Allergan plc | 242,978 | — |
| WELLCARE HEALTH PLANS, INC. | 221,424 | — |
| CAESARS HOLDINGS, INC. | 202,732 | — |
| TD AMERITRADE HOLDING CORP | 195,276 | — |
| WABCO Holdings Inc. | 193,467 | — |
| TIFFANY & CO | 188,262 | — |
| Wright Medical Group N.V. | 183,516 | — |
| CYPRESS SEMICONDUCTOR CORP /DE/ | 178,213 | — |
| MELLANOX TECHNOLOGIES LTD | 172,186 | — |
| MEDICINES CO /DE | 160,777 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
805
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|